RecallRadar

FDA Drug recall D-0793-2017

Ventolin HFA (albuterol sulfate) Inhalation, 90 mcg per actuation, 200 Metered Inhalations, Net Wt. 18 g inhalers, Rx only, GlaxoSmithKline…

On 2017-05-31 the FDA classified a Class II recall of Ventolin HFA (albuterol sulfate) Inhalation, 90 mcg per actuation, 200 Metered Inhalations, Net Wt. 18 g inhalers, Rx only, GlaxoSmithKline… by Glaxosmithkline, citing defective Delivery System: Elevated number of units with out of specification results for leak rate.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0793-2017
ClassificationClass II
Statusongoing
Initiated2017-05-16
Published2017-05-31
Last updated2026-09-13 11:51 UTC
CompanyGlaxosmithkline
DistributionUS

Product

Ventolin HFA (albuterol sulfate) Inhalation, 90 mcg per actuation, 200 Metered Inhalations, Net Wt. 18 g inhalers, Rx only, GlaxoSmithKline, Research Triangle Park, NC 27709, NDC 0173-0682-20.

Reason

Defective Delivery System: Elevated number of units with out of specification results for leak rate

Identifiers

ndc0173-0682-20
ndc0173-0682-24
code_infoLot#: 7ZP0634, 7ZP0810, 7ZP0990, Exp. 5/18

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0793-2017%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.